Siga Technologies: Q2 Earnings Due, New TPOXX Orders A Must
SIGA Technologies Inc SIGA
$3.27
▲ +0.62%
(+$0.02)
💰 High Dividend
📅 Earnings This Week
Open
$3.25
Prev Close
$3.25
Day Range
$3.15 – $3.32
52W Range
$3.01 – $9.62
Market Cap
$234.54M
P/E (TTM)
11.54
Beta
0.92
EPS (TTM)
$0.28
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1997-09-09 |
| Shares Out. | 71,720,000 |
| Website | siga.com/ ↗ |
| Phone | 12126729100 |
| Employees | 49 |
| Revenue | $6.2M |
| Gross Profit | $3.3M |
| Net Income | -$3.5M |
| Free Cash Flow | $27.4M |
| Total Assets | $219.4M |
| Total Liabilities | $67.8M |
| Equity | $151.6M |
About SIGA Technologies Inc
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
SIGA Technologies Inc is a publicly traded company under the ticker symbol SIGA on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.